Corsair Gaming (CRSR) Is Up 31.3% After Buyback Launch And Profit Rebound Amid Softer 2026 Outlook

Simply Wall St

Sat, February 14, 2026 at 5:12 PM GMT+9 3 min read

In this article:

CRSR

+48.25%

Corsair Gaming reported past fourth-quarter 2025 results with sales of US$436.86 million and net income of US$25.79 million, alongside full-year 2025 sales of US$1.47 billion and a reduced net loss of US$16.16 million.

At the same time, the company issued 2026 guidance pointing to about a 5% revenue decline at the midpoint and launched its first US$50 million share repurchase program, highlighting confidence despite pressure from ongoing global semiconductor shortages.

Next, we’ll examine how Corsair’s strong year-end profitability rebound and new share buyback reshape the company’s investment narrative and risk profile.

Explore 23 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

Corsair Gaming Investment Narrative Recap

To own Corsair Gaming, you need to believe the long term demand story for PC gaming and content creation can outweigh near term hardware and tariff headwinds. The latest results show a sharp rebound in year end profitability, but 2026 guidance for roughly a 5% revenue decline and ongoing semiconductor shortages keep the main near term catalyst and risk tightly linked to how well Corsair manages component supply and margins. For now, this news does not remove those core risks.

The most relevant announcement here is Corsair’s first US$50 million share repurchase authorization. Alongside reduced net losses in 2025 and stronger fourth quarter profitability, the buyback adds a new capital allocation lever that could influence per share metrics just as management prepares for a year of softer top line guidance and mixed segment performance, with peripherals growth offset by component and systems pressure.

Yet investors should be aware that ongoing semiconductor shortages and upcoming tariff changes could still materially affect Corsair’s margins and…

Read the full narrative on Corsair Gaming (it’s free!)

Corsair Gaming’s narrative projects $1.9 billion revenue and $75.7 million earnings by 2028.

Uncover how Corsair Gaming’s forecasts yield a $8.75 fair value, a 29% upside to its current price.

Exploring Other Perspectives

CRSR 1-Year Stock Price Chart

Some of the lowest target analysts were already cautious, baking in about US$1.8 billion of 2028 revenue and US$63.1 million of earnings, which contrasts sharply with the more optimistic catalyst that new, graphically intensive games could keep upgrade demand robust; after this guidance update, you and those bearish analysts may view Corsair’s risk reward very differently, so it is worth comparing how your expectations line up with both stories.

繼續閱讀  

Explore 6 other fair value estimates on Corsair Gaming - why the stock might be worth over 3x more than the current price!

Build Your Own Corsair Gaming Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

A great starting point for your Corsair Gaming research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Our free Corsair Gaming research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Corsair Gaming's overall financial health at a glance.

Ready For A Different Approach?

Right now could be the best entry point. These picks are fresh from our daily scans. Don’t delay:

The latest GPUs need a type of rare earth metal called Dysprosium and there are only 30 companies in the world exploring or producing it. Find the list for free.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 28 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

_ This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned._

Companies discussed in this article include CRSR.

Have feedback on this article? Concerned about the content? Get in touch with us directly._ Alternatively, email editorial-team@simplywallst.com_

條款 及 私隱政策

Privacy Dashboard

More Info